Precipio Inc. (NASDAQ: PRPO) stock jumped 4.76% on Friday to $1.54 against a previous-day closing price of $1.47. With 1.27 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.24 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.6900 whereas the lowest price it dropped to was $1.4700. The 52-week range on PRPO shows that it touched its highest point at $4.17 and its lowest point at $0.91 during that stretch. It currently has a 1-year price target of $4.00. Beta for the stock currently stands at 2.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PRPO was up-trending over the past week, with a rise of 32.76%, but this was up by 30.51% over a month. Three-month performance surged to 46.67% while six-month performance rose 17.56%. The stock lost -52.17% in the past year, while it has lost -2.53% so far this year. A look at the trailing 12-month EPS for PRPO yields -0.52 with Next year EPS estimates of 0.00. EPS is expected to grow by 20.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 70.20%.
Float and Shares Shorts:
At present, 22.71 million PRPO shares are outstanding with a float of 21.98 million shares on hand for trading. On Jul 14, 2022, short shares totaled 0.13 million, which was 0.57% higher than short shares on Jun 14, 2022. In addition to Mr. Ilan Danieli as the firm’s Founder, Pres, CEO & Director, Mr. Ahmed Zaki Sabet serves as its Chief Operating Officer.
Through their ownership of 10.48% of PRPO’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 5.80% of PRPO, in contrast to 4.69% held by mutual funds. Shares owned by individuals account for 3.77%. As the largest shareholder in PRPO with 4.58% of the stake, The Vanguard Group, Inc. holds 1,039,510 shares worth 1,039,510. A second-largest stockholder of PRPO, BlackRock Fund Advisors, holds 627,476 shares, controlling over 2.76% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in PRPO, holding 257,126 shares or 1.13% stake. With a 2.92% stake in PRPO, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 662,055 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 1.55% of PRPO stock, is the second-largest Mutual Fund holder. It holds 352,392 shares valued at 0.37 million. Fidelity Extended Market Index Fu holds 0.56% of the stake in PRPO, owning 126,776 shares worth 0.13 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PRPO since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With PRPO analysts setting a high price target of $4.00 and a low target of $4.00, the average target price over the next 12 months is $4.00. Based on these targets, PRPO could surge 159.74% to reach the target high and rise by 159.74% to reach the target low. Reaching the average price target will result in a growth of 159.74% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. PRPO will report FY 2022 earnings on 03/29/2023. Analysts have provided yearly estimates in a range of -$0.21 being high and -$0.21 being low. For PRPO, this leads to a yearly average estimate of -$0.21. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Based on analyst estimates, the high estimate for the next quarter is -$0.05 and the low estimate is -$0.05. The average estimate for the next quarter is thus -$0.05.
Summary of Insider Activity:
Insiders traded PRPO stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 8,063 while 0 shares were sold.